| 6CT7: reference: Development of an aggregate-selective, human-derived alpha-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models., Weihofen A, Liu Y, Arndt JW, Huy C, Quan C, Smith BA, Baeriswyl JL, Cavegn N, Senn L, Su L, Marsh G, Auluck PK, Montrasio F, Nitsch RM, Hirst WD, Cedarbaum JM, Pepinsky RB, Grimm J, Weinreb PH, Neurobiol Dis. 2018 Oct 28;124:276-288. doi: 10.1016/j.nbd.2018.10.016. PMID: 30381260 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).